One Chain Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
21
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
7
One Chain General Information
Description
Developer of biomedicines designed to provide immunotherapies against hematological neoplasms. The company's biomedicines aim to offer treatments based on immunotherapy for different tumors, such as cortical T-cell acute lymphoblastic leukemia (coT-ALL), enabling patients to receive effective treatment for malignancies.
Contact Information
Website
www.onechaintx.comCorporate Office
- Calle Muntaner 383, 3rd 2nd
- 08021 Barcelona
- Spain
Corporate Office
- Calle Muntaner 383, 3rd 2nd
- 08021 Barcelona
- Spain
One Chain Timeline
One Chain Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Accelerator/Incubator | 21-Feb-2025 | Completed | Clinical Trials - General | |||
| 4. Early Stage VC | 22-Jun-2023 | Completed | Clinical Trials - General | |||
| 3. Grant | 23-Feb-2023 | Completed | Clinical Trials - General | |||
| 2. Seed Round | 20-Jul-2020 | $3.44M | $3.44M | Completed | Generating Revenue | |
| 1. Spin-Off | 01-Jun-2020 | Completed | Generating Revenue |
One Chain Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
One Chain Patents
One Chain Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024221674-A1 | Ccr9 targeting moiety for the treatment of ccr9-positive cancer | Pending | 15-Feb-2023 | ||
| EP-4417623-A1 | Ccr9 targeting moiety for the treatment of ccr9-positive cancer | Inactive | 15-Feb-2023 | ||
| EP-4665760-A1 | Ccr9 targeting moiety for the treatment of ccr9-positive cancer | Pending | 15-Feb-2023 | ||
| US-20260232732-A1 | Ccr9 targeting moiety for the treatment of ccr9-positive cancer | Pending | 15-Feb-2023 | ||
| WO-2024170627-A1 | Ccr9 targeting moiety for the treatment of ccr9-positive cancer | Inactive | 15-Feb-2023 | A61K40/11 |
One Chain Signals
One Chain Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Biocat | Accelerator/Incubator | |||
| Clave (Pamplona) | Venture Capital | Minority | ||
| Nara Capital AM | Fund of Funds | Minority | ||
| European Commission | Government | |||
| INNVIERTE SICC | Government | Minority |
One Chain FAQs
-
When was One Chain founded?
One Chain was founded in 2020.
-
Where is One Chain headquartered?
One Chain is headquartered in Barcelona, Spain.
-
What is the size of One Chain?
One Chain has 21 total employees.
-
What industry is One Chain in?
One Chain’s primary industry is Drug Discovery.
-
Is One Chain a private or public company?
One Chain is a Private company.
-
What is One Chain’s current revenue?
The current revenue for One Chain is .
-
How much funding has One Chain raised over time?
One Chain has raised $10.7M.
-
Who are One Chain’s investors?
Biocat, Clave (Pamplona), Nara Capital AM, European Commission, and INNVIERTE SICC are 5 of 7 investors who have invested in One Chain.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process